Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the bioavailability of
insulin degludec and liraglutide, when administered either combined or as separate
administrations.